All products / DC22800
ML-210
Pack sizes and prices
| Pack size | Price |
|---|---|
| 25 mg | $200 USDRequest a quote → |
| 100 mg | $550 USDRequest a quote → |
| 250 mg | $950 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
ML-210,the most potent compound in the nitroisoxazole series, is a selective covalent inhibitor of glutathione peroxidase 4 (GPX4) by binding the selenocysteine residue[1]. ML-210 has IC50s of 71 nM, 272 nM and 107nM for BJeLR (HRASV12), BJeH-LT (without HRASV12) and DRD cell lines, respectively[2].
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC22800 |
|---|---|
| Product name | ML-210 |
| CAS | 1360705-96-9 |
| Molecular formula | C22H20Cl2N4O4 |
| Molecular weight | 475.32460308075 |
| Purity | >98% |
| SMILES | ClC1=CC=C(C(N2CCN(C(C3=NOC(C)=C3[N+]([O-])=O)=O)CC2)C2=CC=C(Cl)C=C2)C=C1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — ML-210 (DC22800)Source references
[1]. John K. Eaton, et al. Targeting a Therapy-Resistant Cancer Cell State Using Masked Electrophiles as GPX4 Inhibitors. Biorxiv. 2018. [2]. Weïwer M, et al. Development of small-molecule probes that selectively kill cells induced to express mutant RAS. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1822-6.
